NLS Pharmaceutics
NLSP
NLSP
4 hedge funds and large institutions have $205K invested in NLS Pharmaceutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$132K |
| 2 |
2
Two Sigma Advisers
New York
|
$34K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$33K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$6K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$0 |
| 3 |
CA
3
Clearstead Advisors
Cleveland,
Ohio
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $132K | +$132K | +1,050 | New |
|
|
2
Two Sigma Advisers
New York
| $34K | +$34K | +270 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $33K | +$33K | +264 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $6K | +$6K | +48 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$148K | -913 | Closed |
|
|
6
Millennium Management
New York
| – | -$134K | -830 | Closed |
|
|
CA
7
Clearstead Advisors
Cleveland,
Ohio
| – | -$1K | -8 | Closed |
|